JP2007506681A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506681A5
JP2007506681A5 JP2006527166A JP2006527166A JP2007506681A5 JP 2007506681 A5 JP2007506681 A5 JP 2007506681A5 JP 2006527166 A JP2006527166 A JP 2006527166A JP 2006527166 A JP2006527166 A JP 2006527166A JP 2007506681 A5 JP2007506681 A5 JP 2007506681A5
Authority
JP
Japan
Prior art keywords
antibody
use according
medicament
asthma
daclizumab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006527166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506681A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/031640 external-priority patent/WO2005030252A1/en
Publication of JP2007506681A publication Critical patent/JP2007506681A/ja
Publication of JP2007506681A5 publication Critical patent/JP2007506681A5/ja
Pending legal-status Critical Current

Links

JP2006527166A 2003-09-23 2004-09-21 抗ｉｌ−２受容体抗体による呼吸器疾患の治療 Pending JP2007506681A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50588303P 2003-09-23 2003-09-23
US55297404P 2004-03-12 2004-03-12
PCT/US2004/031640 WO2005030252A1 (en) 2003-09-23 2004-09-21 Treatment of respiratory diseases with anti-il-2 receptor antibodies

Publications (2)

Publication Number Publication Date
JP2007506681A JP2007506681A (ja) 2007-03-22
JP2007506681A5 true JP2007506681A5 (enExample) 2007-11-08

Family

ID=34396276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006527166A Pending JP2007506681A (ja) 2003-09-23 2004-09-21 抗ｉｌ−２受容体抗体による呼吸器疾患の治療

Country Status (8)

Country Link
US (1) US20050089517A1 (enExample)
EP (1) EP1675615A1 (enExample)
JP (1) JP2007506681A (enExample)
AU (1) AU2004275860A1 (enExample)
BR (1) BRPI0414688A (enExample)
CA (1) CA2538737A1 (enExample)
RU (1) RU2006113701A (enExample)
WO (1) WO2005030252A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE47972E1 (en) 2003-11-08 2020-05-05 Prothera Biologics, Inc. Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
PT2291654T (pt) 2008-05-28 2018-06-15 Prothera Biologics Inc Preparação e composição de proteínas inibidoras de interalfa do sangue
US20110236381A1 (en) * 2008-12-10 2011-09-29 Stavros Garantziotis Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
WO2012155039A1 (en) * 2011-05-12 2012-11-15 Temple University-Of The Commonwealth System Of Higher Education Diagnosis and treatment of copd
CA2885604A1 (en) 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of ischemia using inter-alpha inhibitor proteins
CN109789193A (zh) 2016-09-13 2019-05-21 普罗瑟拉生物公司 使用间α抑制蛋白治疗肺病的方法
BR122020025384B1 (pt) * 2016-12-13 2022-07-12 Delinia, Inc Proteínas de fusão e dimérica, usos das mesmas e composição farmacêutica
CA3061164A1 (en) 2017-04-25 2018-11-01 Prothera Biologics, Inc. Methods for quantifying inter-alpha inhibitor proteins
EP3902584A4 (en) * 2018-12-29 2022-09-07 Kaleo, Inc. DEVICES AND METHODS FOR DELIVERING SUBSTANCES IN A PRE-FILLED SYRINGE
EP4037673A4 (en) * 2019-10-04 2023-08-16 R.P. Scherer Technologies, LLC ANTI-CD25-MAYTANSINE ANTIBODY CONJUGATES AND METHODS OF USE THEREOF
US12268847B1 (en) 2021-02-10 2025-04-08 Kaleo, Inc. Devices and methods for delivery of substances within a medicament container
CN118370816A (zh) * 2024-03-22 2024-07-23 中日友好医院(中日友好临床医学研究所) Il-2/抗il-2抗体免疫复合物的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4411993A (en) * 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
US4845198A (en) * 1984-05-21 1989-07-04 Immunex Corporation Hybridoma antibody which binds IL-2 receptor
US5336489A (en) * 1985-09-05 1994-08-09 The Beth Israel Hospital Association Treatment of allograft rejection with IL-2 receptor-specific cytotoxins
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
AU8910891A (en) * 1990-11-20 1992-06-11 National Heart & Lung Institute, The Treatment of lung diseases
AP960A (en) * 1995-04-14 2001-04-20 Glaxo Wellcome Inc Metered dose inhaler for fluticasone propionate.
US6013256A (en) * 1996-09-24 2000-01-11 Protein Design Labs, Inc. Method of preventing acute rejection following solid organ transplantation
JP3973360B2 (ja) * 1998-07-27 2007-09-12 ノバルティス アクチエンゲゼルシャフト 関節リウマチまたは皮膚疾患の処置に使用するためのｃｄ２５結合分子
CZ20032672A3 (cs) * 2001-04-06 2003-12-17 University Of Bristol CD25 vazebná molekula pro použití při prevenci nebo léčení některých nemocí u pacientů rezistentních na léčbu steroidy
BRPI0316282B8 (pt) * 2002-11-15 2021-05-25 Genmab As anticorpo humano isolado monoclonal, composição, imunoconjugado, molécula biespecífica ou multiespecífica, método e conjunto de diagnóstico para detectar a presença de antígeno cd25 ou uma célula que expressa cd25, e, vetor de expressão

Similar Documents

Publication Publication Date Title
KR102390714B1 (ko) 벤랄리주맙을 이용하여 천식의 악화 속도를 감소시키는 방법
JP2015527364A5 (enExample)
JP2017507139A5 (enExample)
RU2015109716A (ru) Способы лечения или предотвращения астмы посредством введения антагониста il-4r
JP2007506681A5 (enExample)
JP2007522229A5 (enExample)
JP2009511480A5 (enExample)
JP2006527193A5 (enExample)
CA2569077A1 (en) Combinations comprising antimuscarinic agents and corticosteroids
CN107073114B (zh) 使用瑞利珠单抗治疗中度到重度嗜酸细胞性哮喘
IL271132B1 (en) Dry powder aclidinium salt pharmaceutical composition for treatment of copd
RU2006113701A (ru) Лечение респираторных заболеваний антителами против рецептора il-2
JP2019528316A5 (enExample)
CA2568571A1 (en) Combinations comprising antimuscarinic agents and corticosteroids
JP2008110991A (ja) 処置方法
JP2015511625A5 (enExample)
KR102337601B1 (ko) 벤랄리주맙을 이용하여 천식 증상을 개선시키는 방법
JP2013525310A5 (enExample)
JP2014012683A5 (enExample)
TWI870471B (zh) 全身性硬化症治療用醫藥組合物
Kuhn Immunoglobulin E blockade in the treatment of asthma
Masekela et al. Asthma treatment in children: A pragmatic approach
Smith Fixed-combination inhalers for asthma and chronic obstructive pulmonary disease
EP4267184B1 (en) Interleukin 5 binding protein dosage regimen
US20250042985A1 (en) Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic syndrome, chronic rhinosinusitis with nasal polyps (crswnp), or chronic rhinosinusitis without nasal polyps (crssnp)